Pharma Reaserch Prod Co Ltd (214450) — Capital Reinvestment Ratio
Latest as of December 2025:
0.13x
Pharma Reaserch Prod Co Ltd (214450) has a Capital Reinvestment Ratio of 0.13x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩61.53 Billion) in capital expenditures (₩7.79 Billion). See 214450 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.13x
Capex / Operating Cash Flow
Operating Cash Flow
₩61.53 Billion
KRW
Capital Expenditures
₩7.79 Billion
KRW
Data as of
Dec 2025
Most recent filing
Pharma Reaserch Prod Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Pharma Reaserch Prod Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see 214450 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | ₩183.16 Billion | ₩35.78 Billion | ▼ -29.4% |
| 2024 | 0.28x | ₩139.88 Billion | ₩38.73 Billion | ▲ +36.2% |
| 2023 | 0.20x | ₩64.95 Billion | ₩13.20 Billion | ▼ -32.0% |
| 2022 | 0.30x | ₩59.40 Billion | ₩17.76 Billion | ▼ -5.5% |
| 2021 | 0.32x | ₩65.30 Billion | ₩20.64 Billion | ▼ -70.6% |
| 2020 | 1.07x | ₩32.39 Billion | ₩34.78 Billion | ▲ +115.9% |
| 2019 | 0.50x | ₩19.27 Billion | ₩9.59 Billion | ▼ -91.0% |
| 2018 | 5.50x | ₩5.20 Billion | ₩28.60 Billion | ▲ +516.2% |
| 2017 | 0.89x | ₩8.56 Billion | ₩7.63 Billion | ▲ +271.8% |
| 2016 | 0.24x | ₩8.16 Billion | ₩1.96 Billion | ▲ +730.2% |
| 2015 | 0.03x | ₩16.02 Billion | ₩462.99 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow